A large Cochrane review of 67 randomized trials (>2,300 patients) found no clear evidence that ketamine or other NMDA-receptor antagonists reduce chronic non-cancer pain. Evidence quality was rated low to very low, so current data do not reliably support ketamine as an effective pain treatment.
